Legacy Financial Group (Oklahoma)’s AbbVie ABBV Stock Holding History

Legacy Financial Group (Oklahoma)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$559K	Sell	2,222 -21	-0.9%	-$4.52K	0.13%	52
2026 Q1	$488K	Buy	2,243 +203	+10%	+$45K	0.13%	53
2025 Q4	$466K	Buy	2,040 +9	+0.4%	+$2.05K	0.12%	54
2025 Q3	$470K	Sell	2,031 -23	-1%	-$4.68K	0.13%	52
2025 Q2	$381K	Sell	2,054 -377	-16%	-$70.1K	0.11%	55
2025 Q1	$509K	Sell	2,431 -10	-0.4%	-$1.94K	0.16%	47
2024 Q4	$434K	Sell	2,441 -13	-0.5%	-$2.39K	0.14%	52
2024 Q3	$500K	Sell	2,454 -1,228	-33%	-$229K	0.17%	45
2024 Q2	$631K	Buy	3,682 +1	+0%	+$166	0.24%	39
2024 Q1	$670K	Buy	3,681 +198	+6%	+$34.1K	0.26%	38
2023 Q4	$540K	Sell	3,483 -611	-15%	-$89.1K	0.24%	39
2023 Q3	$610K	Sell	4,094 -6	-0.1%	-$881	0.3%	35
2023 Q2	$552K	Buy	4,100 +328	+9%	+$48.1K	0.28%	37
2023 Q1	$601K	Buy	3,772 +99	+3%	+$15.1K	0.33%	30
2022 Q4	$594K	Buy	+3,673	New	+$563K	0.37%	30

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Legacy Financial Group (Oklahoma)'s ABBV Position: Q2 2026 in Review

Legacy Financial Group (Oklahoma) reduced its AbbVie (ABBV) stake by 0.94% in Q2 2026, selling an estimated $4.52K and leaving 2,222 shares worth $559K. The position accounts for 0.13% of the portfolio, ranked #52.

Legacy Financial Group (Oklahoma) first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $670K in Q1 2024. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Legacy Financial Group (Oklahoma) held 2,222 shares of AbbVie worth $559K as of Q2 2026.
Legacy Financial Group (Oklahoma) sold 21 AbbVie shares in Q2 2026, an estimated $4.52K.
AbbVie made up 0.13% of Legacy Financial Group (Oklahoma)'s portfolio in Q2 2026, its #52 holding.
Legacy Financial Group (Oklahoma) first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
Legacy Financial Group (Oklahoma)'s AbbVie position peaked at $670K in Q1 2024.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Legacy Financial Group (Oklahoma)'s 13F filing for Q2 2026, filed 30 Jul 2026.